🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/07/2009 | 42,50 | 43,60 | 42,10 | 42,80 | +1,31% | 3,52% | 878.400 |
| 22/07/2009 | 42,90 | 43,20 | 42,01 | 42,25 | -1,47% | 2,79% | 1.296.800 |
| 21/07/2009 | 42,90 | 43,49 | 42,81 | 42,88 | +0,81% | 1,60% | 1.419.400 |
| 20/07/2009 | 41,95 | 42,90 | 41,53 | 42,53 | +1,87% | 3,28% | 1.214.400 |
| 17/07/2009 | 41,84 | 41,99 | 41,00 | 41,75 | +0,08% | 2,37% | 810.200 |
| 16/07/2009 | 42,06 | 42,11 | 41,50 | 41,72 | -0,70% | 1,46% | 1.133.800 |
| 15/07/2009 | 42,28 | 42,28 | 41,41 | 42,01 | +0,30% | 2,06% | 999.600 |
| 14/07/2009 | 40,53 | 42,16 | 40,02 | 41,89 | +3,04% | 5,27% | 1.508.400 |
| 13/07/2009 | 40,50 | 40,70 | 39,88 | 40,65 | +0,73% | 2,02% | 959.400 |
| 10/07/2009 | 40,02 | 40,87 | 39,93 | 40,36 | +0,25% | 2,35% | 563.200 |
| 09/07/2009 | 39,98 | 40,43 | 39,74 | 40,26 | +0,78% | 1,71% | 621.800 |
| 08/07/2009 | 39,36 | 40,12 | 39,36 | 39,95 | +1,60% | 1,92% | 838.600 |
| 07/07/2009 | 39,89 | 40,30 | 38,98 | 39,32 | -2,53% | 3,31% | 704.800 |
| 06/07/2009 | 40,92 | 40,92 | 39,64 | 40,34 | -1,75% | 3,12% | 1.098.400 |
| 02/07/2009 | 41,00 | 41,25 | 40,19 | 41,06 | -1,51% | 2,60% | 744.600 |
| 01/07/2009 | 41,70 | 42,49 | 41,48 | 41,69 | +0,05% | 2,43% | 882.400 |
| 30/06/2009 | 41,99 | 42,40 | 41,16 | 41,67 | -0,23% | 2,97% | 967.000 |
| 29/06/2009 | 41,67 | 41,99 | 40,70 | 41,76 | +1,51% | 3,11% | 1.204.600 |
| 26/06/2009 | 43,00 | 43,28 | 40,96 | 41,14 | -4,16% | 5,40% | 8.908.600 |
| 25/06/2009 | 41,37 | 42,93 | 41,00 | 42,93 | +3,51% | 4,65% | 1.037.800 |
| 24/06/2009 | 41,12 | 41,72 | 40,52 | 41,47 | +1,77% | 2,92% | 620.800 |
| 23/06/2009 | 40,92 | 41,67 | 40,35 | 40,75 | +0,38% | 3,21% | 684.600 |
| 22/06/2009 | 41,40 | 41,56 | 40,17 | 40,60 | -1,83% | 3,37% | 868.400 |
| 19/06/2009 | 42,15 | 42,34 | 41,35 | 41,35 | -0,40% | 2,36% | 1.110.000 |
| 18/06/2009 | 41,86 | 42,11 | 41,32 | 41,52 | -1,06% | 1,88% | 764.800 |
| 17/06/2009 | 41,25 | 42,71 | 41,25 | 41,96 | +1,82% | 3,54% | 965.600 |
| 16/06/2009 | 41,54 | 41,91 | 40,94 | 41,21 | -0,77% | 2,35% | 1.256.800 |
| 15/06/2009 | 42,02 | 42,25 | 41,15 | 41,53 | -2,21% | 2,62% | 659.600 |
| 12/06/2009 | 42,63 | 42,91 | 42,08 | 42,47 | -0,13% | 1,96% | 529.400 |
| 11/06/2009 | 41,65 | 43,26 | 41,41 | 42,53 | +2,58% | 4,44% | 1.300.600 |